METROPOLIS HEALTHCARE
|
METROPOLIS HEALTHCARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 27.90 | 41.86 | 35.82 | 25.15 | 23.94 |
| CEPS(Rs) | 45.42 | 54.31 | 44.86 | 33.05 | 28.92 |
| DPS(Rs) | 8.00 | 8.00 | 8.00 | 8.00 | 13.26 |
| Book NAV/Share(Rs) | 191.54 | 170.88 | 136.57 | 102.99 | 82.89 |
| Tax Rate(%) | 23.52 | 26.82 | 24.96 | 24.33 | 33.48 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 25.35 | 28.14 | 29.04 | 27.69 | 26.79 |
| EBIT Margin(%) | 19.10 | 25.92 | 25.64 | 21.24 | 25.24 |
| Pre Tax Margin(%) | 16.33 | 23.88 | 24.48 | 19.76 | 24.70 |
| PAT Margin (%) | 12.49 | 17.48 | 18.37 | 14.95 | 16.43 |
| Cash Profit Margin (%) | 20.26 | 22.62 | 22.98 | 19.54 | 19.06 |
| Performance Ratios | |||||
| ROA(%) | 8.30 | 15.31 | 18.43 | 14.78 | 15.51 |
| ROE(%) | 15.46 | 27.31 | 30.07 | 27.33 | 30.17 |
| ROCE(%) | 19.83 | 34.39 | 41.60 | 37.90 | 45.10 |
| Asset Turnover(x) | 0.66 | 0.88 | 1.00 | 0.99 | 0.94 |
| Sales/Fixed Asset(x) | 0.88 | 1.48 | 2.48 | 2.69 | 2.94 |
| Working Capital/Sales(x) | 30.41 | 13.41 | 2.47 | 3.76 | 4.22 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.13 | 0.68 | 0.40 | 0.37 | 0.34 |
| Receivable days | 40.91 | 38.40 | 45.94 | 56.49 | 56.95 |
| Inventory Days | 15.21 | 13.62 | 11.88 | 10.76 | 11.34 |
| Payable days | 142.17 | 141.34 | 141.56 | 114.33 | 82.24 |
| Valuation Parameters | |||||
| PER(x) | 44.76 | 48.66 | 62.57 | 51.15 | - |
| PCE(x) | 27.50 | 37.50 | 49.96 | 38.92 | - |
| Price/Book(x) | 6.52 | 11.92 | 16.41 | 12.49 | - |
| Yield(%) | 0.64 | 0.39 | 0.36 | 0.62 | - |
| EV/Net Sales(x) | 5.56 | 8.56 | 11.06 | 7.36 | -0.07 |
| EV/Core EBITDA(x) | 20.68 | 28.75 | 36.56 | 25.65 | -0.25 |
| EV/EBIT(x) | 29.09 | 33.02 | 43.13 | 34.64 | -0.27 |
| EV/CE(x) | 3.73 | 6.03 | 10.42 | 6.78 | -0.07 |
| M Cap / Sales | 5.57 | 8.48 | 11.48 | 7.60 | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | -6.52 | 23.08 | 16.53 | 12.51 | 17.62 |
| Core EBITDA Growth(%) | -15.62 | 21.16 | 22.84 | 15.80 | 13.92 |
| EBIT Growth(%) | -31.10 | 24.42 | 40.67 | -5.31 | 14.88 |
| PAT Growth(%) | -33.21 | 17.09 | 43.16 | 2.42 | 11.80 |
| EPS Growth(%) | -33.34 | 16.85 | 42.43 | 5.03 | -78.08 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.08 | 0.30 | - | - | 0.04 |
| Current Ratio(x) | 1.12 | 1.25 | 2.68 | 2.08 | 1.75 |
| Quick Ratio(x) | 0.98 | 1.11 | 2.52 | 1.97 | 1.64 |
| Interest Cover(x) | 6.89 | 12.72 | 22.13 | 14.38 | 46.64 |
| Total Debt/Mcap(x) | 0.01 | 0.02 | - | - | - |
Compare Financial Ratios of peers of METROPOLIS HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| METROPOLIS HEALTHCARE | ₹8,945.7 Cr | 4.8% | -5.2% | 29.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹91,073.2 Cr | 3.4% | -6.6% | 49% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹79,502.4 Cr | 5.7% | -8.7% | 59.1% | Stock Analytics | |
| GLOBAL HEALTH | ₹37,303.7 Cr | 6.7% | -13.1% | 164.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹33,297.4 Cr | 2.6% | -6.4% | 59.4% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹26,105.1 Cr | 2% | -9.6% | 59.5% | Stock Analytics | |
METROPOLIS HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| METROPOLIS HEALTHCARE | 4.8% |
-5.2% |
29.3% |
| SENSEX | -2.4% |
-1% |
21.3% |
You may also like the below Video Courses
